...
首页> 外文期刊>Gynecologic Oncology: An International Journal >Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in China
【24h】

Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in China

机译:耐久性的HPV测试提供了临床表现的耐用性:中国的15年队列研究

获取原文
获取原文并翻译 | 示例
           

摘要

ObjectiveSelf-collected HPV testing could substantially reduce disparities in cervical cancer screening, with slightly lower sensitivity compared to physician-collected specimens cross-sectionally. We aimed to evaluate the comprehensive long-term performance of self-collected HPV testing prospectively. MethodsIn 1999, 1997 women were screened by HPV testing on self-collected and physician-collected samples, cytology and visual inspection with acetic acid (VIA) and followed up in 2005, 2010 and 2014, respectively. HPV testing was performed with Hybrid Capture II. Prospective performance, baseline clinical efficiency, and 15-year cumulative risk of cervical intraepithelial neoplasia grade 2 or higher (CIN2+) were analyzed. ResultsSelf-collected HPV testing prospectively detected 83.3% (95% CI:74.9%,89.3%), 70.3% (95% CI:62.5%,77.2%) and 63.3% (95% CI:55.7%, 70.2%) of cumulative CIN2+ at 6-year, 11-year and 15-year follow-up, respectively. Relative cumulative sensitivity of physician-collected HPV testing versus self-collected HPV testing was stable over 15?years at about 1.16. Cumulative sensitivity of self-collected HPV testing was comparable to cytology and significantly higher than VIA. Among women positive by self-collected HPV testing at baseline, 26.2% (95% CI:21.5%, 30.9%) developed CIN2+ during 6-year follow-up and no difference was observed with physician-collected HPV testing even 15?years after baseline. Negative self-collected HPV results provided greater protection against CIN2+ than VIA and ascertained CIN2+ cumulative incident rates as low as 1.1% at the 6-year follow-up. ConclusionsSelf-collected HPV testing demonstrates lower sensitivity than physician-collected HPV testing but performs comparably to cytology prospectively and provides satisfactory assurance against CIN2+, indicating an alternative role in cervical cancer primary screening with five-year interval as an option especially in low-resource settings.
机译:受体摄取的HPV测试可以大大降低宫颈癌筛查中的差异,与横截面的医生收集的试样相比,敏感性略低。我们旨在评估前瞻性的自集HPV测试的全面长期表现。方法1999年,1997年的妇女通过HPV检测通过HPV检测对自集和医师收集的样品,细胞学和醋酸(VIA)的目视检查,并分别随访于2005年和2014年。用杂种捕获II进行HPV测试。分析了前瞻性性能,基线临床效率和15年的宫颈上皮内瘤级或更高(CIN2 +)的累积风险。结果来自收集的HPV测试预期检测到83.3%(95%CI:74.9%,89.3%),70.3%(95%CI:62.5%,77.2%)和63.3%(95%CI:55.7%,70.2%)累积CIN2 +分别为6年,11年和15年的随访。收集的HPV测试的相对累积敏感性与自收集的HPV测试稳定超过15?年约1.16。自集的HPV测试的累积敏感性与细胞学相当,显着高于VIA。在基线上自收集的HPV测试阳性的女性中,26.2%(95%CI:21.5%,30.9%)在6年后续行动期间开发了CIN2 +,并且没有用医师收集的HPV测试甚至没有差异,甚至15?年后基线。消极的自集HPV结果提供了更大的防止CIN2 +的保护,而不是通过6年随访时间低至1.1%的CIN2 +累积事件。结论,收集的HPV测试表明,比医生收集的HPV检测更低的灵敏度,但对患有CIN2 +的细胞学进行了令人满意的保证,表明宫颈癌初级筛查具有五年间隔的替代作用,特别是在低资源环境中的选择。 。

著录项

  • 来源
  • 作者单位

    Department of Cancer Epidemiology National Cancer Center/National Clinical Research Center for;

    Department of Cancer Epidemiology National Cancer Center/National Clinical Research Center for;

    Department of Cancer Epidemiology National Cancer Center/National Clinical Research Center for;

    Department of Cancer Epidemiology National Cancer Center/National Clinical Research Center for;

    Department of Pathology National Cancer Center/National Clinical Research Center for Cancer/Cancer;

    Department of Cytology National Cancer Center/National Clinical Research Center for Cancer/Cancer;

    Department of Gynecological Oncology National Cancer Center/National Clinical Research Center for;

    Department of Cancer Epidemiology National Cancer Center/National Clinical Research Center for;

    Department of Cancer Epidemiology National Cancer Center/National Clinical Research Center for;

    Department of Cancer Epidemiology National Cancer Center/National Clinical Research Center for;

    XiangyuanWomen and Children's Hospital;

    Screening Group Section of Early Detection and Prevention International Agency for Research on;

    Department of Cancer Epidemiology National Cancer Center/National Clinical Research Center for;

    Department of Cancer Epidemiology National Cancer Center/National Clinical Research Center for;

    Screening Group Section of Early Detection and Prevention International Agency for Research on;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    Self-collected HPV testing; Prospective cohort; Cervical cancer screening;

    机译:自收集的HPV测试;未来队列;宫颈癌筛查;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号